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Functional mitral regurgitation as a determinant of pulmonary
hypertension in heart failure with preserved left ventricular
ejection fraction
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Background.— Several studies suggest that BNP testing may help
deﬁne the timing of aortic valve surgery in patients with aortic
valve stenosis (AVS) prior onset of overt LV systolic dysfunction. The
aim of this study was to identify predictors of plasma BNP levels
in a large cohort of patients with AVS and preserved LV ejection
fraction.
Method and results.— One hundred and thirty-ﬁve consecutive
patients were prospectively included in the present study (mean
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Objectives.— Functional MR may occur in heart failure with pre-
served ejection fraction (HFpEF) as elevated left atrial pressure
disrupts normal functioning of the mitral valve apparatus. Whether
functional MR contributes to pulmonary hypertension (PH) in HFpEF
remains unknown.
Material and methods.— Systolic pulmonary artery pressure (sPAP)
was assessed using Doppler echocardiography in 70 ambulatory
HFpEF patients and 70 hypertensive controls without organic lesions
of the mitral valve.
Results.— sPAP and E/e’ were greater in HFpEF patients than in
controls (29± 8 vs 35± 9, P < 0.0001 and 11± 5 vs 13± 6, P = 0.018
respectively). While none of controls had more than trivial MR, 21
patients with HFpEF had mild to moderate MR (mean mitral ERO,
RV and regurgitant fraction 7± 3mm2, 15± 8mm2, and 28± 14%
respectively). After adjusting for E/e’, sPAP remained greater in
HFpEF patients than in controls (P = 0.002). Pulmonary hypertension
was signiﬁcantly more prevalent in HFpEF patients with functional
MR than in HFpEF patients without functional MR (62 vs 22%,
P = 0.002). Functional MR remained an independent predictor of
PH in HFpEF patients (P = 0.004) after adjustment on E/e’ ratio
(P = 0.022) and LA volume index (P = 0.025).
Conclusion.— Besides severity of LV diastolic dysfunction, functional
MR appears as a key determinant of pulmonary hypertension in
HFpEF.
doi:10.1016/j.acvd.2011.03.063
Determinants of plasma B-type natriuretic peptide levels in
patients with aortic valve stenosis and normal left ventricular
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1875-2136/$ — see front matterge 73± 13-year-old, 66 [49%] male, 89 [66%]) with severe aor-
ic valve stenosis [aortic valve area < 0.6 cm2/m2 BSA]). Plasma
NP levels, clinical and comprehensive Doppler echocardiography
valuation was performed in all patients. Independent clinical pre-
ictors of plasma BNP levels (R2 = 0.19) were older age (P < 0.0001)
nd presence of AVS symptoms (P = 0.004). Independent echocardio-
raphic predictors of plasma BNP levels (R2 = 0.38) were E/e’ ratio
P = 0.01), LV mass index (P = 0.018), left atrial surface (P < 0.0001)
nd systolic pulmonary artery pressure (sPAP) (P = 0.004). Overall,
ndependent predictors of plasma BNP levels (R2 = 0.47) were older
ge (P = 0.001), known coronary artery disease (P = 0.047), increased
V mass index (P = 0.001), left atrial enlargement (P = 0.002), and
ncreased sPAP (P = 0.003).
onclusions.— In patients with AVS and normal LV ejection fraction,
lasma BNP predominantly reﬂects the clinical and echocardio-
raphic consequences of afterload burden imposed on the left
entricle rather than the severity of valve stenosis, per se. This
ay account for the strong prognostic value of BNP beyond indices
f valvular stenosis severity in patients with AVS.
oi:10.1016/j.acvd.2011.03.064
owards a noninvasive assessment of valve biology:
chocardiographic measures of mitral leaﬂet distensibility
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ackground.— Changes in mitral valve (MV) elasticity or distensibil-
ty occur in disease and directly affect MV function, contributing to
V prolapse (MVP) or ﬂail versus restricted coaptation of stiffer
eaﬂets in functional mitral regurgitation (FMR) and MV stenosis
MS). Recent studies suggest MV distensibility may be modiﬁed to
educe MR, but distensibility has only been measured in excised MVs.
ur aim was to test the feasibility of obtaining a noninvasive mea-
ure of MV distensibility in patients by measuring systolic change in
nterior leaﬂet length (ALL) or anterior leaﬂet strain; and to test
